Search

Your search keyword '"Panchanathan, Sarada S."' showing total 10 results
Start Over Author "Panchanathan, Sarada S."
10 results on '"Panchanathan, Sarada S."'

2. Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years--United States, June 17, 2022-May 7, 2023

Author

Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Moro, Pedro L., Myers, Tanya R., Bradley, Colin, Bazel, Samaneh, Panchanathan, Sarada S., Shimabukuro, Tom T., and Shay, David K.

Subjects
Pfizer Inc. -- Safety and security measures, United States. Food and Drug Administration -- Safety and security measures, Diseases, Complications and side effects, Safety and security measures, Vaccines -- Complications and side effects, Medical research -- Safety and security measures, Vaccination -- Safety and security measures, Pharmaceutical industry -- Safety and security measures, COVID-19 -- Complications and side effects, Messenger RNA -- Safety and security measures, Medicine, Experimental -- Safety and security measures
Abstract

As of May 7, 2023, CDC's Advisory Committee on Immunization Practices (ACIP) recommends that all children aged 6 months--5 years receive at least 1 age-appropriate bivalent mRNA COVID-19 vaccine dose. [...]

Published
2023

3. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years--United States, October 12-January 1, 2023

Author

Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Su, John R., Myers, Tanya R., Gee, Julianne, Panchanathan, Sarada S., Thompson, Deborah, Shimabukuro, Tom T., and Shay, David K.

Subjects
Pfizer Inc. -- Safety and security measures, United States. Food and Drug Administration -- Safety and security measures, Safety and security measures, Health aspects, Vaccines -- Safety and security measures -- Health aspects, Vaccination -- Health aspects -- Safety and security measures, Pharmaceutical industry -- Safety and security measures -- Health aspects, COVID-19 -- Safety and security measures -- Health aspects, Messenger RNA -- Safety and security measures -- Health aspects
Abstract

On October 12, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for bivalent (mRNA encoding the spike protein from the SARS-CoV-2 ancestral strain and BA.4/BA.5 Omicron [...]

Published
2023

4. COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years--United States, June 18, 2022-August 21,2022

Author

Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Myers, Tanya R., Gee, Julianne, Su, John R., Parker, Casey, Thompson, Deborah, Panchanathan, Sarada S., Shimabukuro, Tom T., and Shay, David K.

Subjects
Pfizer Inc. -- Safety and security measures, United States. Food and Drug Administration -- Safety and security measures, Complications and side effects, Safety and security measures, Vaccines -- Complications and side effects, COVID-19 -- Complications and side effects, Messenger RNA -- Safety and security measures, Children's furniture -- Safety and security measures
Abstract

On June 17, 2022, the Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for mRNA COVID-19 vaccines to include children aged 6 months-4 years for receipt of [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results